Literature DB >> 3376892

Relation of left ventricular function and Na,K-pump concentration in suspected idiopathic dilated cardiomyopathy.

A Nørgaard1, J P Bagger, P Bjerregaard, U Baandrup, K Kjeldsen, P E Thomsen.   

Abstract

The possible relation between Na-K-pump concentration and left ventricular (LV) function was studied in 24 patients with suspected idiopathic dilated cardiomyopathy. This was done by measurement of 3H-ouabain binding to biopsies obtained during left-sided heart catheterization. In all patients light microscopy of biopsies was compatilel with dilated cardiomyopathy. Nineteen patients had impaired LV function as defined by NYHA/WHO and a Na,K-pump concentration of 331 +/- 19 pmol/g wet weight, whereas 5 patients had normal LV function and a Na,K-pump concentration of 559 +/- 62 pmol/g wet weight (p less than 0.001). The correlation between Na,K-pump concentration and ejection fraction was highly significant n = 24, r = 0.81, p less than 0.001). There was no correlation between volume fraction of collagen tissue and Na,K-pump concentration in the biopsies (n = 24, r = -0.08, p less than 0.80), indicating that the decrease in Na,K-pump concentration with dilated cardiomyopathy is not the simple outcome of increased fibrosis in the myocardium. The results indicate that the decrease in Na,K-pump concentration may be of importance for myocardial dysfunction and suggest a simple biochemical assessment of dilated cardiomyopathy by measurement of 3H-ouabain binding.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3376892     DOI: 10.1016/0002-9149(88)91175-7

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  21 in total

1.  Reduction of Na/K-ATPase potentiates marinobufagenin-induced cardiac dysfunction and myocyte apoptosis.

Authors:  Changxuan Liu; Yan Bai; Yiliang Chen; Yu Wang; Yoann Sottejeau; Lijun Liu; Xiaomei Li; Jerry B Lingrel; Deepak Malhotra; Christopher J Cooper; Joseph I Shapiro; Zi-jian Xie; Jiang Tian
Journal:  J Biol Chem       Date:  2012-03-27       Impact factor: 5.157

2.  Myocardial region (right or left ventricle) and aetiology of heart failure can influence the inotropic effect of ouabain in failing human myocardium.

Authors:  R Padrini; M Panfili; G Magnolfi; D Piovan; D Casarotto; M Ferrari
Journal:  Br J Clin Pharmacol       Date:  1999-11       Impact factor: 4.335

3.  Quantification of the total Na,K-ATPase concentration in atria and ventricles from mammalian species by measuring 3H-ouabain binding to intact myocardial samples. Stability to short term ischemia reperfusion.

Authors:  T A Schmidt; J H Svendsen; S Haunsø; K Kjeldsen
Journal:  Basic Res Cardiol       Date:  1990 Jul-Aug       Impact factor: 17.165

Review 4.  Sodium potassium adenosine triphosphatase (Na/K-ATPase) as a therapeutic target for uremic cardiomyopathy.

Authors:  Xiaoliang Wang; Jiang Liu; Christopher A Drummond; Joseph I Shapiro
Journal:  Expert Opin Ther Targets       Date:  2017-04-03       Impact factor: 6.902

5.  Effect of amiodarone on 3H-ouabain binding sites in human skeletal muscle.

Authors:  A Nørgaard; J H Jensen; F Andreasen
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

6.  Reduction of Na/K-ATPase affects cardiac remodeling and increases c-kit cell abundance in partial nephrectomized mice.

Authors:  Christopher A Drummond; Moustafa Sayed; Kaleigh L Evans; Huilin Shi; Xiaoliang Wang; Steven T Haller; Jiang Liu; Christopher J Cooper; Zijian Xie; Joseph I Shapiro; Jiang Tian
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-04-18       Impact factor: 4.733

7.  Myocardial Na,K-ATPase: Clinical aspects.

Authors:  Keld Kjeldsen
Journal:  Exp Clin Cardiol       Date:  2003

8.  Reduced 3H-ouabain binding site (Na,K-ATPase) concentration in ventricular myocardium of dogs with tachycardia induced heart failure.

Authors:  T A Schmidt; J S Larsen; R P Shannon; K Komamura; D E Vatner; K Kjeldsen
Journal:  Basic Res Cardiol       Date:  1993 Nov-Dec       Impact factor: 17.165

9.  Dysfunction of ouabain-induced cardiac contractility in mice with heart-specific ablation of Na,K-ATPase beta1-subunit.

Authors:  Sonali P Barwe; Maria C Jordan; Anna Skay; Landon Inge; Sigrid A Rajasekaran; Daniel Wolle; Christina L Johnson; Patricia Neco; Kun Fang; Nora Rozengurt; Joshua I Goldhaber; Kenneth P Roos; Ayyappan K Rajasekaran
Journal:  J Mol Cell Cardiol       Date:  2009-08-15       Impact factor: 5.000

10.  Digoxin and mortality in atrial fibrillation: a prospective cohort study.

Authors:  Pär Hallberg; Johan Lindbäck; Bertil Lindahl; Ulf Stenestrand; Håkan Melhus
Journal:  Eur J Clin Pharmacol       Date:  2007-08-08       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.